TrialJournal of the Pediatric Infectious Diseases Society2026

A Phase 3 Study of Ensitrelvir in Japanese Participants Aged 6-11 Years with SARS-CoV-2 Infection.

Takashi Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.